Interleukin 4-producing CD4+ T cells in the skin of cats with allergic dermatitis

P J Roosje1, G A Dean, T Willemse

  • 1Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

Insights

Feline allergic dermatitis involves interleukin 4 (IL4) producing CD4+ T cells, similar to human atopic dermatitis. This indicates IL4

Area of Science:

  • Veterinary Immunology
  • Dermatology
  • Immunopathology

Background:

  • Feline allergic dermatitis shares similarities with human atopic dermatitis, including cellular infiltrates and CD4/CD8 T cell ratios.
  • CD4+ helper T cells, particularly the Th2 subset, are crucial in human atopic dermatitis pathogenesis.
  • The role of specific cytokine production by T cells in feline allergic dermatitis remains largely unexplored.

Purpose of the Study:

  • To investigate the cytokine profile of CD4+ T cells in cats with allergic dermatitis.
  • To determine the presence and source of interleukin 4 (IL4) production in feline skin lesions.
  • To compare the immunological findings in cats with those observed in human atopic dermatitis.

Main Methods:

  • Immunohistochemistry was employed to detect IL4-producing CD4+ T cells in lesional and nonlesional skin biopsies.
  • Double staining techniques were used to identify cell types (pan-T, CD4, mast cell chymase) expressing IL4.
  • Western blotting confirmed the cross-reactivity of antibodies against human IL4 with feline IL4.

Main Results:

  • CD4+ T cells in both lesional and nonlesional skin of cats with allergic dermatitis were found to produce IL4.
  • The number of IL4-producing T cells was significantly higher in affected cats compared to healthy controls (P = 0.001).
  • IL4 was primarily localized to CD4+ T cells, with minimal co-localization with mast cells.

Conclusions:

  • Interleukin 4 (IL4) is produced by CD4+ T cells in feline allergic dermatitis, mirroring findings in human atopic dermatitis.
  • The presence of IL4 in clinically unaffected skin suggests its involvement in the early or ongoing pathogenesis of the disease.
  • These findings highlight a potential therapeutic target for feline allergic dermatitis by modulating IL4 pathways.